Sana Biotechnology, Inc. Shares Outstanding (Cover Page)
Sana Biotechnology, Inc. (SANA) had Shares Outstanding (Cover Page) of 299.36 million shares as of 2026-08-03, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-03: Entity Common Stock, Shares Outstanding 299.36M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 278.29M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 266.87M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 266.37M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 299.36M shares 10-Q · filed 2026-08-10 |
| 2026-04-30 | 278.29M shares 10-Q · filed 2026-05-11 |
| 2026-02-24 | 266.87M shares 10-K · filed 2026-03-03 |
| 2025-10-29 | 266.37M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 237.81M shares 10-Q · filed 2025-08-11 |
| 2025-04-30 | 225.56M shares 10-Q · filed 2025-05-08 |
| 2025-03-10 | 225.02M shares 10-K · filed 2025-03-17 |
| 2024-10-31 | 223.27M shares 10-Q · filed 2024-11-08 |
| 2024-07-31 | 222.47M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 221.50M shares 10-Q · filed 2024-05-08 |
| 2024-02-22 | 220.45M shares 10-K · filed 2024-02-29 |
| 2023-10-31 | 197.13M shares 10-Q · filed 2023-11-08 |
| 2023-07-27 | 196.94M shares 10-Q · filed 2023-08-03 |
| 2023-05-01 | 191.50M shares 10-Q · filed 2023-05-08 |
| 2023-03-10 | 191.36M shares 10-K · filed 2023-03-16 |
| 2022-10-27 | 190.73M shares 10-Q · filed 2022-11-02 |
| 2022-07-29 | 190.23M shares 10-Q · filed 2022-08-04 |
| 2022-05-06 | 189.67M shares 10-Q · filed 2022-05-10 |
| 2022-03-11 | 189.54M shares 10-K · filed 2022-03-16 |
| 2021-11-05 | 188.83M shares 10-Q · filed 2021-11-08 |
| 2021-08-03 | 187.89M shares 10-Q · filed 2021-08-04 |
| 2021-05-04 | 187.68M shares 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |